Impact of COVID-19 vaccination in post-COVID cardiac complications

Josefina B Parodi1, Agustín Indavere1, Pamela Bobadilla Jacob1

  • 1Instituto Cardiovascular Lezica, Buenos Aires, Argentina.

Vaccine
|February 1, 2023
PubMed

Insights

COVID-19 vaccination significantly reduces the risk of post-COVID cardiac complications and persistent long-COVID symptoms. Fully vaccinating the population is crucial for mitigating these adverse health outcomes following infection.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Post-COVID-19 infection can lead to cardiac complications and persistent long-COVID symptoms.
  • While COVID-19 vaccination reduces mortality and ICU admissions, its impact on post-COVID cardiac issues remains understudied.
  • Understanding vaccination's role in preventing cardiac sequelae is vital for public health strategies.

Purpose of the Study:

  • To investigate the association between COVID-19 vaccination status and the prevalence of post-COVID cardiac injury.
  • To evaluate the relationship between COVID-19 vaccination and the occurrence of persistent long-COVID cardiac symptoms.
  • To assess echocardiographic findings in vaccinated versus unvaccinated individuals post-COVID-19.

Main Methods:

  • Retrospective analysis of 1883 patients evaluated for post-COVID conditions.
  • Exclusion of patients with pre-existing heart disease.
  • Multivariate analysis adjusted for age, sex, and clinical variables to assess vaccination's impact on cardiac injury and persistent symptoms.

Main Results:

  • Vaccination was linked to a significantly lower prevalence of cardiac injury (1.35% vs. 4.11%, adjusted OR 0.33, p=0.01).
  • The vaccinated group exhibited a lower prevalence of persistent long-COVID symptoms (10.7% vs. 18.3%, adjusted OR 0.52, p<0.001).
  • A complete vaccination scheme was defined as at least two doses administered 14 days or more prior to evaluation.

Conclusions:

  • COVID-19 vaccination is associated with a reduced risk of post-COVID cardiac complications.
  • Vaccination correlates with a lower incidence of persistent long-COVID symptoms.
  • These findings underscore the importance of widespread COVID-19 vaccination for preventing adverse cardiac sequelae.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
21
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
22
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
18
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
28
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21